BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3624042)

  • 1. Serum tissue polypeptide antigen (TPA): a marker of acute injury of salivary glands during radiation therapy.
    Becciolini A; Tommasi MS; Porciani S; Fantappiè B; Cellai E; Chiavacci A
    Int J Radiat Oncol Biol Phys; 1987 Sep; 13(9):1339-42. PubMed ID: 3624042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposal for biochemical dosimeter for prolonged space flights.
    Becciolini A; Porciani S; Lanini A; Balzi M; Faraoni P
    Phys Med; 2001; 17 Suppl 1():185-6. PubMed ID: 11776255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum amylase and tissue polypeptide antigen as biochemical indicators of salivary gland injury during iodine-131 therapy.
    Becciolini A; Porciani S; Lanini A; Benucci A; Castagnoli A; Pupi A
    Eur J Nucl Med; 1994 Oct; 21(10):1121-5. PubMed ID: 7828622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marker determination for response monitoring: radiotherapy and disappearance curves.
    Becciolini A; Porciani S; Lanini A
    Int J Biol Markers; 1994; 9(1):38-42. PubMed ID: 7519652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma amylase activity as a biochemical indicator of radiation injury to salivary glands.
    Becciolini A; Giannardi G; Cionini L; Porciani S; Fallai C; Pirtoli L
    Acta Radiol Oncol; 1984; 23(1):9-14. PubMed ID: 6203336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer].
    Kuhnt T; Jirsak N; Müller AC; Pelz T; Gernhardt C; Schaller HG; Janich M; Gerlach R; Dunst J
    Strahlenther Onkol; 2005 Aug; 181(8):520-8. PubMed ID: 16044220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scintigraphic assessment of salivary function and excretion response in radiation-induced injury of the major salivary glands.
    Valdés Olmos RA; Keus RB; Takes RP; van Tinteren H; Baris G; Hilgers FJ; Hoefnagel CA; Balm AJ
    Cancer; 1994 Jun; 73(12):2886-93. PubMed ID: 8199984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative radiation dose-response relationships for normal tissues in man. II. Response of the salivary glands during radiotherapy.
    Mossman KL
    Radiat Res; 1983 Aug; 95(2):392-8. PubMed ID: 6611856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary gland sparing in the treatment of head and neck cancer.
    Scrimger R
    Expert Rev Anticancer Ther; 2011 Sep; 11(9):1437-48. PubMed ID: 21929317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy requirements for head and neck intensity-modulated radiation therapy based on observed dose response of the major salivary glands.
    Kapanen M; Collan J; Saarilahti K; Heikkonen J; Kairemo K; Tenhunen M
    Radiother Oncol; 2009 Oct; 93(1):109-14. PubMed ID: 19435641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary results of a pilot study using WR-2721 before fractionated irradiation of the head and neck to reduce salivary gland dysfunction.
    McDonald S; Meyerowitz C; Smudzin T; Rubin P
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):747-54. PubMed ID: 8040020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of pilocarpine during head and neck radiation therapy to reduce xerostomia and salivary dysfunction.
    Valdez IH; Wolff A; Atkinson JC; Macynski AA; Fox PC
    Cancer; 1993 Mar; 71(5):1848-51. PubMed ID: 8448748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Normal tissue tolerance to external beam radiation therapy: salivary glands].
    Ortholan C; Benezery K; Bensadoun RJ
    Cancer Radiother; 2010 Jul; 14(4-5):290-4. PubMed ID: 20609609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of oral problems after radiation of the head and neck].
    Eleftheriadis I
    Hell Period Stomat Gnathopathoprosopike Cheir; 1990 Jun; 5(2):77-80. PubMed ID: 2130060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine.
    Münter MW; Hoffner S; Hof H; Herfarth KK; Haberkorn U; Rudat V; Huber P; Debus J; Karger CP
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):651-9. PubMed ID: 17175118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy.
    Münter MW; Karger CP; Hoffner SG; Hof H; Thilmann C; Rudat V; Nill S; Wannenmacher M; Debus J
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):175-84. PubMed ID: 14697436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of radioprotective effect of pilocarpine ingestion on salivary glands.
    Pimentel MJ; Filho MM; Araújo M; Gomes DQ; DA Costa LJ
    Anticancer Res; 2014 Apr; 34(4):1993-9. PubMed ID: 24692737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Assessment of radiation injuries to the salivary glands after treatment of head and neck cancers].
    Urban A; Miszczyk L; Maciejewski B
    Otolaryngol Pol; 2005; 59(1):21-5. PubMed ID: 15915914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of radiotherapy on taste and salivary function in man.
    Mossman K; Shatzman A; Chencharick J
    Int J Radiat Oncol Biol Phys; 1982 Jun; 8(6):991-7. PubMed ID: 7107441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major salivary gland function in patients with radiation-induced xerostomia: flow rates and sialochemistry.
    Valdez IH; Atkinson JC; Ship JA; Fox PC
    Int J Radiat Oncol Biol Phys; 1993 Jan; 25(1):41-7. PubMed ID: 8416881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.